How long is the wait to get into an Aducanumab study?
What would it mean if Aducanumab is proven effective in reference to finding a cure?
What are the risks of taking aducanumab (Aduhelm)?
FDA Moves Forward on Aducanumab
In yet another encouraging step toward the development of what could be the first drug approved for Alzheimer’s disease, the Federal Drug Administration today…
Biogen Seeks FDA Approval for Alzheimer’s Drug Aducanumab
In another step toward what could be the first treatment for early stage Alzheimer’s, Biogen and Eisai today said they have completed an application…
FDA Gives Biogen Green Light to Relaunch Aducanumab Study on Trial Participants
The U.S. Food and Drug Administration (FDA) has approved a re-dosing study for patients formerly enrolled in Biogen’s phase three clinical trials of its…
What Biogen’s Relaunch of Alzheimer’s Drug Aducanumab Means For The Search For A Cure
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease after all, and that it would be reviving a…
Will Biogen’s Drug Aducanumab Solve the Alzheimer’s Mystery?
Last week, Biogen announced that its Alzheimer’s drug aducanumab was effective in combating Alzheimer’s disease, and that it would be reviving a trial cancelled…
Biogen Revives Aducanumab, Experimental Alzheimer’s Drug, to Submit for FDA Approval
In a dizzying reversal, Biogen announced today that it would seek approval from the U.S. Food and Drug Administration (FDA) to begin marketing its…
There’s a New Bill of Rights for People With Alzheimer’s
Now, there is a bill of rights for people living with Alzheimer’s disease. It was drafted by the patient-founded nonprofit organization Voices of Alzheimer’s. …
Alzheimer’s Drug Decision Pushed: FDA Slows Down on Donanemab
The Food and Drug Administration has decided to postpone its decision on the approval of Eli Lilly’s candidate Alzheimer’s drug, donanemab. The delay has…
Alzheimer’s Drugs and ARIA: Leqembi ‘Brain Bleeds’ Side Effect, Explained
Neurologists and Alzheimer’s research experts explain the side effect known as ARIA — or brain bleeds — associated with the use of anti-amyloid monoclonal antibody…
Dementia Biomarkers 101: What Does Beta-Amyloid Do In the Brain?
If you or a loved one is going through the diagnostic process for Alzheimer’s, one of the terms you’re likely to hear quite a…
An Army Vet’s 23&Me Test Inspired Him to Join a Clinical Trial. There, He Learned He Had Early Signs of Alzheimer’s
Biogen and Eisai’s monoclonal antibody drugs for Alzheimer’s — Aduhelm (now off the market) and Leqembi (fully approved by the FDA in 2023) —…